PGNY Stock: Price, Earnings History and SEC Filings
Progyny, Inc. (PGNY) last traded at $29.19, up 2.78% on the latest session and up 15.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.34 against an analyst estimate of $0.28, a beat of 21.4%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PGNY earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.34 | $0.28 | +21.43% |
| Mar 2026 | May 7, 2026 | $0.29 | $0.24 | +20.83% |
| Dec 2025 | Feb 26, 2026 | $0.14 | $0.13 | +7.69% |
| Sep 2025 | Nov 6, 2025 | $0.15 | $0.13 | +15.38% |
PGNY beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How PGNY reacts to earnings
Across its last 8 earnings releases, PGNY moved 13.0% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | After close | -6.98% |
| 2026-05-07 | After close | +23.80% |
| 2026-02-26 | After close | -20.49% |
| 2026-01-12 | Before open | +5.30% |
| 2025-11-06 | After close | +24.21% |
| 2025-08-07 | After close | -0.91% |
| 2025-07-08 | Before open | +13.15% |
| 2025-05-08 | After close | -9.33% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
PGNY financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $1.3B | $59M | $192M | 4.5% | $0.65 |
| 2024 | $1.2B | $54M | $174M | 4.7% | $0.57 |
| 2023 | $1.1B | $62M | $185M | 5.7% | $0.62 |
| 2022 | $787M | $30M | $77M | 3.9% | $0.30 |
| 2021 | $501M | $66M | $24M | 13.1% | $0.66 |
| 2020 | $345M | $46M | $35M | 13.5% | $0.47 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for PGNY
- 10-Q · Aug 7, 2026
- 8-K · Aug 6, 2026Results of operations, Regulation FD disclosure
- 8-K · May 27, 2026Bylaw change, Shareholder vote
- 8-K · May 26, 2026Other events
- 10-Q · May 8, 2026
- 8-K · May 7, 2026Results of operations, Regulation FD disclosure
- DEF 14A · Apr 10, 2026
- 8-K · Mar 13, 2026Other events
- 10-K · Feb 27, 2026
- 8-K · Feb 26, 2026Results of operations, Regulation FD disclosure
Insider filing activity
PGNY insiders filed 9 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
PGNY news
- Progyny (PGNY) Cuts Guidance And Puts Its Valuation Back In FocusNov 1, 2026 · finance.yahoo.com
- Progyny (PGNY) Stock Looks About Right On Its 56% RunNov 1, 2026 · finance.yahoo.com
- Is Lower Revenue Guidance Altering The Investment Case For Progyny Stock (PGNY)?Nov 1, 2026 · finance.yahoo.com
- Progyny’s (PGNY) Full-Year Guidance Lowered on Utilization HeadwindsOct 30, 2026 · finance.yahoo.com
- 1 cash-producing stock for long-term investors and 2 we find riskyOct 29, 2026 · finance.yahoo.com
- 3 Reasons to sell PGNY and 1 stock to buy insteadOct 28, 2026 · finance.yahoo.com
- New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to BenefitsOct 28, 2026 · finance.yahoo.com
- New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care ModelOct 26, 2026 · finance.yahoo.com
About Progyny, Inc.
Progyny, Inc. (PGNY) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-misc Health & Allied Services NEC. It is incorporated in DE. Its fiscal year ends in December.